aluates Reports

$ 0.0

Automative

Global Anti-allergic Drugs Market Research Report 2026

Published Date: 2026-04-08

Report Code: QYRE-Auto-16R9189

Global Anti allergic Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Anti-allergic Drugs Market Research Report 2026

Code: QYRE-Auto-16R9189

Report

2026-04-08

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

TEVA

GlaxoSmithKline PLC

Bayer

Sun Pharma

UCB Pharma

Yangtze River Pharmaceutical Group

Hainan Poly Pharm

Chongqing Huapont Pharmaceutical

Dawnrays

Johnson and Johnson

Sanofi

Astrazeneca plc

Roche

Novartis

Anti-allergic Drugs Market Size

The global Anti-allergic Drugs market was valued at US$ 47760 million in 2025 and is anticipated to reach US$ 75120 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Anti-allergic Drugs Market

Anti-allergic drugs are medications used to treat and prevent allergic reactions by targeting the immune system's response to allergens. These drugs help alleviate symptoms associated with allergies, such as sneezing, itching, runny nose, rashes, or swelling, and are commonly used for conditions like hay fever, allergic rhinitis, and skin allergies. Common types of anti-allergic drugs include antihistamines, corticosteroids, decongestants, and leukotriene inhibitors. These medications work by blocking histamines or other inflammatory substances that the body releases during an allergic reaction, reducing the severity of symptoms and providing relief to individuals suffering from allergies.

Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.

This report delivers a comprehensive overview of the global Anti-allergic Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-allergic Drugs. The Anti-allergic Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Anti-allergic Drugs market comprehensively. Regional market sizes by Type, by Sales Channel, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Anti-allergic Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Sales Channel, and by region.

Market Segmentation

Scope of Anti-allergic Drugs Market Report

Report Metric	Details
Report Name	Anti-allergic Drugs Market
Accounted market size in 2025	US$ 47760 million
Forecasted market size in 2032	US$ 75120 million
CAGR	6.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Oral Drugs Non-Oral Drugs Inhalation and Nasal Sprays
Segment by Sales Channel	Online Offline
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Johnson And Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Sun Pharma, UCB Pharma, Yangtze River Pharmaceutical Group, Hainan Poly Pharm, Chongqing Huapont Pharmaceutical, Dawnrays, AstraZeneca, Roche, Novartis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Sales Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Anti-allergic Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Sales Channel, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Anti-allergic Drugs Market growing?

Ans: The Anti-allergic Drugs Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Anti-allergic Drugs Market size in 2032?

Ans: The Anti-allergic Drugs Market size in 2032 will be US$ 75120 million.

What is the market share of major companies in Anti-allergic Drugs Market?

Ans: Global top two companies hold a share over 10%.

Who are the main players in the Anti-allergic Drugs Market report?

Ans: The main players in the Anti-allergic Drugs Market are Sanofi, Johnson And Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Sun Pharma, UCB Pharma, Yangtze River Pharmaceutical Group, Hainan Poly Pharm, Chongqing Huapont Pharmaceutical, Dawnrays, AstraZeneca, Roche, Novartis

What are the Type segmentation covered in the Anti-allergic Drugs Market report?

Ans: The Types covered in the Anti-allergic Drugs Market report are Oral Drugs, Non-Oral Drugs, Inhalation and Nasal Sprays

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anti-allergic Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Oral Drugs

1.2.3 Non-Oral Drugs

1.2.4 Inhalation and Nasal Sprays

1.3 Market by Sales Channel

1.3.1 Global Anti-allergic Drugs Market Growth by Sales Channel: 2021 vs 2025 vs 2032

1.3.2 Online

1.3.3 Offline

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Anti-allergic Drugs Market Perspective (2021–2032)

2.2 Global Anti-allergic Drugs Growth Trends by Region

2.2.1 Global Anti-allergic Drugs Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Anti-allergic Drugs Historic Market Size by Region (2021–2026)

2.2.3 Anti-allergic Drugs Forecasted Market Size by Region (2027–2032)

2.3 Anti-allergic Drugs Market Dynamics

2.3.1 Anti-allergic Drugs Industry Trends

2.3.2 Anti-allergic Drugs Market Drivers

2.3.3 Anti-allergic Drugs Market Challenges

2.3.4 Anti-allergic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Anti-allergic Drugs Players by Revenue

3.1.1 Global Top Anti-allergic Drugs Players by Revenue (2021–2026)

3.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2021–2026)

3.2 Global Top Anti-allergic Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Anti-allergic Drugs Revenue

3.4 Global Anti-allergic Drugs Market Concentration Ratio

3.4.1 Global Anti-allergic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anti-allergic Drugs Revenue in 2025

3.5 Global Key Players of Anti-allergic Drugs Head Offices and Areas Served

3.6 Global Key Players of Anti-allergic Drugs, Products and Applications

3.7 Global Key Players of Anti-allergic Drugs, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Anti-allergic Drugs Breakdown Data by Type

4.1 Global Anti-allergic Drugs Historic Market Size by Type (2021–2026)

4.2 Global Anti-allergic Drugs Forecasted Market Size by Type (2027–2032)

5 Anti-allergic Drugs Breakdown Data by Sales Channel

5.1 Global Anti-allergic Drugs Historic Market Size by Sales Channel (2021–2026)

5.2 Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2027–2032)

6 North America

6.1 North America Anti-allergic Drugs Market Size (2021–2032)

6.2 North America Anti-allergic Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Anti-allergic Drugs Market Size by Country (2021–2026)

6.4 North America Anti-allergic Drugs Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Anti-allergic Drugs Market Size (2021–2032)

7.2 Europe Anti-allergic Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Anti-allergic Drugs Market Size by Country (2021–2026)

7.4 Europe Anti-allergic Drugs Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Anti-allergic Drugs Market Size (2021–2032)

8.2 Asia-Pacific Anti-allergic Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Anti-allergic Drugs Market Size by Region (2021–2026)

8.4 Asia-Pacific Anti-allergic Drugs Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Anti-allergic Drugs Market Size (2021–2032)

9.2 Latin America Anti-allergic Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Anti-allergic Drugs Market Size by Country (2021–2026)

9.4 Latin America Anti-allergic Drugs Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Anti-allergic Drugs Market Size (2021–2032)

10.2 Middle East & Africa Anti-allergic Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Anti-allergic Drugs Market Size by Country (2021–2026)

10.4 Middle East & Africa Anti-allergic Drugs Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Anti-allergic Drugs Introduction

11.1.4 Sanofi Revenue in Anti-allergic Drugs Business (2021–2026)

11.1.5 Sanofi Recent Development

11.2 Johnson And Johnson

11.2.1 Johnson And Johnson Company Details

11.2.2 Johnson And Johnson Business Overview

11.2.3 Johnson And Johnson Anti-allergic Drugs Introduction

11.2.4 Johnson And Johnson Revenue in Anti-allergic Drugs Business (2021–2026)

11.2.5 Johnson And Johnson Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Anti-allergic Drugs Introduction

11.3.4 Merck Revenue in Anti-allergic Drugs Business (2021–2026)

11.3.5 Merck Recent Development

11.4 Teva

11.4.1 Teva Company Details

11.4.2 Teva Business Overview

11.4.3 Teva Anti-allergic Drugs Introduction

11.4.4 Teva Revenue in Anti-allergic Drugs Business (2021–2026)

11.4.5 Teva Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Anti-allergic Drugs Introduction

11.5.4 GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2021–2026)

11.5.5 GlaxoSmithKline Recent Development

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Anti-allergic Drugs Introduction

11.6.4 Bayer Revenue in Anti-allergic Drugs Business (2021–2026)

11.6.5 Bayer Recent Development

11.7 Sun Pharma

11.7.1 Sun Pharma Company Details

11.7.2 Sun Pharma Business Overview

11.7.3 Sun Pharma Anti-allergic Drugs Introduction

11.7.4 Sun Pharma Revenue in Anti-allergic Drugs Business (2021–2026)

11.7.5 Sun Pharma Recent Development

11.8 UCB Pharma

11.8.1 UCB Pharma Company Details

11.8.2 UCB Pharma Business Overview

11.8.3 UCB Pharma Anti-allergic Drugs Introduction

11.8.4 UCB Pharma Revenue in Anti-allergic Drugs Business (2021–2026)

11.8.5 UCB Pharma Recent Development

11.9 Yangtze River Pharmaceutical Group

11.9.1 Yangtze River Pharmaceutical Group Company Details

11.9.2 Yangtze River Pharmaceutical Group Business Overview

11.9.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Introduction

11.9.4 Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2021–2026)

11.9.5 Yangtze River Pharmaceutical Group Recent Development

11.10 Hainan Poly Pharm

11.10.1 Hainan Poly Pharm Company Details

11.10.2 Hainan Poly Pharm Business Overview

11.10.3 Hainan Poly Pharm Anti-allergic Drugs Introduction

11.10.4 Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2021–2026)

11.10.5 Hainan Poly Pharm Recent Development

11.11 Chongqing Huapont Pharmaceutical

11.11.1 Chongqing Huapont Pharmaceutical Company Details

11.11.2 Chongqing Huapont Pharmaceutical Business Overview

11.11.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Introduction

11.11.4 Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2021–2026)

11.11.5 Chongqing Huapont Pharmaceutical Recent Development

11.12 Dawnrays

11.12.1 Dawnrays Company Details

11.12.2 Dawnrays Business Overview

11.12.3 Dawnrays Anti-allergic Drugs Introduction

11.12.4 Dawnrays Revenue in Anti-allergic Drugs Business (2021–2026)

11.12.5 Dawnrays Recent Development

11.13 AstraZeneca

11.13.1 AstraZeneca Company Details

11.13.2 AstraZeneca Business Overview

11.13.3 AstraZeneca Anti-allergic Drugs Introduction

11.13.4 AstraZeneca Revenue in Anti-allergic Drugs Business (2021–2026)

11.13.5 AstraZeneca Recent Development

11.14 Roche

11.14.1 Roche Company Details

11.14.2 Roche Business Overview

11.14.3 Roche Anti-allergic Drugs Introduction

11.14.4 Roche Revenue in Anti-allergic Drugs Business (2021–2026)

11.14.5 Roche Recent Development

11.15 Novartis

11.15.1 Novartis Company Details

11.15.2 Novartis Business Overview

11.15.3 Novartis Anti-allergic Drugs Introduction

11.15.4 Novartis Revenue in Anti-allergic Drugs Business (2021–2026)

11.15.5 Novartis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

TEVA

GlaxoSmithKline PLC

Bayer

Sun Pharma

UCB Pharma

Yangtze River Pharmaceutical Group

Hainan Poly Pharm

Chongqing Huapont Pharmaceutical

Dawnrays

Johnson and Johnson

Sanofi

Astrazeneca plc

Roche

Novartis

List of Tables

Table 1. Global Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Oral Drugs

Table 3. Key Players of Non-Oral Drugs

Table 4. Key Players of Inhalation and Nasal Sprays

Table 5. Global Anti-allergic Drugs Market Size Growth by Sales Channel (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Anti-allergic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Anti-allergic Drugs Market Size by Region (US$ Million), 2021–2026

Table 8. Global Anti-allergic Drugs Market Share by Region (2021–2026)

Table 9. Global Anti-allergic Drugs Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Anti-allergic Drugs Market Share by Region (2027–2032)

Table 11. Anti-allergic Drugs Market Trends

Table 12. Anti-allergic Drugs Market Drivers

Table 13. Anti-allergic Drugs Market Challenges

Table 14. Anti-allergic Drugs Market Restraints

Table 15. Global Anti-allergic Drugs Revenue by Players (US$ Million), 2021–2026

Table 16. Global Anti-allergic Drugs Market Share by Players (2021–2026)

Table 17. Global Top Anti-allergic Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anti-allergic Drugs Revenue, 2025

Table 18. Ranking of Global Top Anti-allergic Drugs Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Anti-allergic Drugs Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Anti-allergic Drugs, Headquarters and Area Served

Table 21. Global Key Players of Anti-allergic Drugs, Products and Applications

Table 22. Global Key Players of Anti-allergic Drugs, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Anti-allergic Drugs Market Size by Type (US$ Million), 2021–2026

Table 25. Global Anti-allergic Drugs Revenue Market Share by Type (2021–2026)

Table 26. Global Anti-allergic Drugs Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Anti-allergic Drugs Revenue Market Share by Type (2027–2032)

Table 28. Global Anti-allergic Drugs Market Size by Sales Channel (US$ Million), 2021–2026

Table 29. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2021–2026)

Table 30. Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (US$ Million), 2027–2032

Table 31. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2027–2032)

Table 32. North America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Anti-allergic Drugs Market Size by Country (US$ Million), 2021–2026

Table 34. North America Anti-allergic Drugs Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Anti-allergic Drugs Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Anti-allergic Drugs Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Anti-allergic Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Anti-allergic Drugs Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Anti-allergic Drugs Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Anti-allergic Drugs Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Anti-allergic Drugs Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Anti-allergic Drugs Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Anti-allergic Drugs Market Size by Country (US$ Million), 2027–2032

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Anti-allergic Drugs Product

Table 50. Sanofi Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 51. Sanofi Recent Development

Table 52. Johnson And Johnson Company Details

Table 53. Johnson And Johnson Business Overview

Table 54. Johnson And Johnson Anti-allergic Drugs Product

Table 55. Johnson And Johnson Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 56. Johnson And Johnson Recent Development

Table 57. Merck Company Details

Table 58. Merck Business Overview

Table 59. Merck Anti-allergic Drugs Product

Table 60. Merck Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 61. Merck Recent Development

Table 62. Teva Company Details

Table 63. Teva Business Overview

Table 64. Teva Anti-allergic Drugs Product

Table 65. Teva Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 66. Teva Recent Development

Table 67. GlaxoSmithKline Company Details

Table 68. GlaxoSmithKline Business Overview

Table 69. GlaxoSmithKline Anti-allergic Drugs Product

Table 70. GlaxoSmithKline Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 71. GlaxoSmithKline Recent Development

Table 72. Bayer Company Details

Table 73. Bayer Business Overview

Table 74. Bayer Anti-allergic Drugs Product

Table 75. Bayer Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 76. Bayer Recent Development

Table 77. Sun Pharma Company Details

Table 78. Sun Pharma Business Overview

Table 79. Sun Pharma Anti-allergic Drugs Product

Table 80. Sun Pharma Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 81. Sun Pharma Recent Development

Table 82. UCB Pharma Company Details

Table 83. UCB Pharma Business Overview

Table 84. UCB Pharma Anti-allergic Drugs Product

Table 85. UCB Pharma Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 86. UCB Pharma Recent Development

Table 87. Yangtze River Pharmaceutical Group Company Details

Table 88. Yangtze River Pharmaceutical Group Business Overview

Table 89. Yangtze River Pharmaceutical Group Anti-allergic Drugs Product

Table 90. Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 91. Yangtze River Pharmaceutical Group Recent Development

Table 92. Hainan Poly Pharm Company Details

Table 93. Hainan Poly Pharm Business Overview

Table 94. Hainan Poly Pharm Anti-allergic Drugs Product

Table 95. Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 96. Hainan Poly Pharm Recent Development

Table 97. Chongqing Huapont Pharmaceutical Company Details

Table 98. Chongqing Huapont Pharmaceutical Business Overview

Table 99. Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product

Table 100. Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 101. Chongqing Huapont Pharmaceutical Recent Development

Table 102. Dawnrays Company Details

Table 103. Dawnrays Business Overview

Table 104. Dawnrays Anti-allergic Drugs Product

Table 105. Dawnrays Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 106. Dawnrays Recent Development

Table 107. AstraZeneca Company Details

Table 108. AstraZeneca Business Overview

Table 109. AstraZeneca Anti-allergic Drugs Product

Table 110. AstraZeneca Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 111. AstraZeneca Recent Development

Table 112. Roche Company Details

Table 113. Roche Business Overview

Table 114. Roche Anti-allergic Drugs Product

Table 115. Roche Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 116. Roche Recent Development

Table 117. Novartis Company Details

Table 118. Novartis Business Overview

Table 119. Novartis Anti-allergic Drugs Product

Table 120. Novartis Revenue in Anti-allergic Drugs Business (US$ Million), 2021–2026

Table 121. Novartis Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Anti-allergic Drugs Picture

Figure 2. Global Anti-allergic Drugs Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Anti-allergic Drugs Market Share by Type: 2025 vs 2032

Figure 4. Oral Drugs Features

Figure 5. Non-Oral Drugs Features

Figure 6. Inhalation and Nasal Sprays Features

Figure 7. Global Anti-allergic Drugs Market Size by Sales Channel (US$ Million), 2021–2032

Figure 8. Global Anti-allergic Drugs Market Share by Sales Channel: 2025 vs 2032

Figure 9. Online Case Studies

Figure 10. Offline Case Studies

Figure 11. Anti-allergic Drugs Report Years Considered

Figure 12. Global Anti-allergic Drugs Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Anti-allergic Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Anti-allergic Drugs Market Share by Region: 2025 vs 2032

Figure 15. Global Anti-allergic Drugs Market Share by Players in 2025

Figure 16. Global Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Anti-allergic Drugs Revenue in 2025

Figure 18. North America Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Anti-allergic Drugs Market Share by Country (2021–2032)

Figure 20. United States Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Anti-allergic Drugs Market Share by Country (2021–2032)

Figure 24. Germany Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Anti-allergic Drugs Market Share by Region (2021–2032)

Figure 32. China Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Anti-allergic Drugs Market Share by Country (2021–2032)

Figure 40. Mexico Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Anti-allergic Drugs Market Share by Country (2021–2032)

Figure 44. Israel Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Anti-allergic Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Sanofi Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 48. Johnson And Johnson Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 49. Merck Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 50. Teva Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 51. GlaxoSmithKline Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 52. Bayer Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 53. Sun Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 54. UCB Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 55. Yangtze River Pharmaceutical Group Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 56. Hainan Poly Pharm Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 57. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 58. Dawnrays Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 59. AstraZeneca Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 60. Roche Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 61. Novartis Revenue Growth Rate in Anti-allergic Drugs Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antihistamine Medications Market Research Report 2025

Global Hay Fever Drug Market Research Report 2025

Global Spray Allergy Rhinitis Drug Market Research Report 2024

Global Allergy and Sinus Medicine Market Research Report 2025

Global Allergy Treatment Loratadine Market Research Report 2024

Global Antihistamine Loratadine Market Research Report 2024

Global Anti nasal Allergy Gel Market Research Report 2024

Global Allergy Medicine Market Research Report 2024

OTC Antihistamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Loratadine Market Insights Forecast to 2030

Global Antihistamine Nose Spray Market Research Report 2024

Global Allergy Diagnostic and Treatment Market Research Report 2024

Global Antihistamine Spray Market Research Report 2024

Antihistamine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Allergy Treatment Drugs Market Research Report 2025

Global Cold and Allergy Remedie Market Insights Forecast to 2030

Global Cough and Allergy Remedie Market Insights Forecast to 2030

Global Allergic Rhinitis Immunotherapies Market Research Report 2024

Hay Fever and Allergic Rhinitis Antihistamines Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions